HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.
CME information and select publications here.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.